These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 10718698)

  • 1. Oseltamivir for flu prevention.
    Johnson JM; Force RW
    J Fam Pract; 2000 Feb; 49(2):183-4. PubMed ID: 10718698
    [No Abstract]   [Full Text] [Related]  

  • 2. Neuraminidase inhibitors slightly beneficial for shortening flu symptoms.
    Phillips TG
    J Fam Pract; 2003 Oct; 52(10):747-8. PubMed ID: 14529590
    [No Abstract]   [Full Text] [Related]  

  • 3. Is oral oseltamivir safe and effective for the prevention of influenza and its complications in frail elderly long-term care residents who have received influenza vaccine?
    Sturpe D; Seaton TL
    J Fam Pract; 2002 Jan; 51(1):87. PubMed ID: 11927075
    [No Abstract]   [Full Text] [Related]  

  • 4. Oseltamivir: new preparation. An antiviral agent with little impact on influenza.
    Prescrire Int; 2003 Jun; 12(65):85-8. PubMed ID: 12825569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral oseltamivir in human experimental influenza B infection.
    Hayden FG; Jennings L; Robson R; Schiff G; Jackson H; Rana B; McClelland G; Ipe D; Roberts N; Ward P
    Antivir Ther; 2000 Sep; 5(3):205-13. PubMed ID: 11075941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A multicenter randomized controlled study of the efficacy and safety of oseltamivir in the treatment of influenza in a high risk population].
    Lin JT; Yu XZ; Cui DJ; Chen XY; Zhu JH; Wang YZ; Wu XD; Gao H; Huo ZL; Zhu SH; Hu SL; Wang AX
    Zhonghua Jie He He Hu Xi Za Zhi; 2004 Jul; 27(7):455-9. PubMed ID: 15312558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of oseltamivir treatment on influenza-related lower respiratory tract complications and hospitalizations.
    Kaiser L; Wat C; Mills T; Mahoney P; Ward P; Hayden F
    Arch Intern Med; 2003 Jul; 163(14):1667-72. PubMed ID: 12885681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Highly selective virostatic therapy. Influenza wave could have been stopped].
    Leshel-Hauzeneder M
    MMW Fortschr Med; 2003 Mar; 145(13):54-5. PubMed ID: 15101538
    [No Abstract]   [Full Text] [Related]  

  • 10. Updated treatment for influenza A and B.
    Montalto NJ; Gum KD; Ashley JV
    Am Fam Physician; 2000 Dec; 62(11):2467-76. PubMed ID: 11130232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [New diagnostic possibilities and medications. Fit for influenza?].
    Wutzler P
    MMW Fortschr Med; 2002 Nov; 144(48):18. PubMed ID: 12532540
    [No Abstract]   [Full Text] [Related]  

  • 12. Oseltamivir and the influenza alphabet.
    Baum SG
    Clin Infect Dis; 2006 Aug; 43(4):445-6. PubMed ID: 16838233
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuraminidase inhibitors in the management of influenza--experience of an outpatient practice.
    Vogel GE
    Med Microbiol Immunol; 2002 Dec; 191(3-4):161-3. PubMed ID: 12458352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early therapy with the neuraminidase inhibitor oseltamivir maximizes its efficacy in influenza treatment.
    Gillissen A; Höffken G
    Med Microbiol Immunol; 2002 Dec; 191(3-4):165-8. PubMed ID: 12458353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oseltamivir for influenza.
    Drug Ther Bull; 2002 Dec; 40(12):89-91. PubMed ID: 12613182
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing the effectiveness of oseltamivir and amantadine for the treatment of influenza: a multicenter study from Japan of the 2002-2003 influenza season.
    Kawai N; Ikematsu H; Iwaki N; Satoh I; Kawashima T; Maeda T; Miyachi K; Hirotsu N; Shigematsu T; Kashiwagi S
    Clin Infect Dis; 2005 May; 40(9):1309-16. PubMed ID: 15825034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Management of influenza in households: a prospective, randomized comparison of oseltamivir treatment with or without postexposure prophylaxis.
    Hayden FG; Belshe R; Villanueva C; Lanno R; Hughes C; Small I; Dutkowski R; Ward P; Carr J
    J Infect Dis; 2004 Feb; 189(3):440-9. PubMed ID: 14745701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Influenza or flu-like infection? Diagnosis has consequences for therapy].
    MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688203
    [No Abstract]   [Full Text] [Related]  

  • 19. [English meta-analysis on zanamivir and oseltamivir. Knowledge of effects of influenza agents still not sufficient].
    Liedholm H
    Lakartidningen; 2003 Dec; 100(50):4186-9. PubMed ID: 14717007
    [No Abstract]   [Full Text] [Related]  

  • 20. A comparison of the effectiveness of oseltamivir for the treatment of influenza A and influenza B: a Japanese multicenter study of the 2003-2004 and 2004-2005 influenza seasons.
    Kawai N; Ikematsu H; Iwaki N; Maeda T; Satoh I; Hirotsu N; Kashiwagi S
    Clin Infect Dis; 2006 Aug; 43(4):439-44. PubMed ID: 16838232
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.